Download PDF
Aktuelle Neurologie 2013; 40(02): 90-95
DOI: 10.1055/s-0032-1332849
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Leitliniengerechte medikamentöse Therapie des chronischen Rückenschmerzes

Evidence-Based Treatment of Chronic Low Back Pain
M. Maschke
1   Abteilung für Neurologie und Neurophysiologie, Krankenhaus der Barmherzigen Brüder Trier
,
M. A. Überall
2   Institut für Neurowissenschaften, Algesiologie und Pädiatrie (IFNAP), Nürnberg
› Author Affiliations
Further Information

Publication History

Publication Date:
23 January 2013 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Der chronische lumbale Rückenschmerz (syn.: chronischer Kreuzschmerz) ist eine der in der Medizin am häufigsten vorkommende Erkrankung mit einer immensen volkswirtschaftlichen Bedeutung. Die Ätiologie ist dabei vielfältig, wobei gerade in den letzten Jahren genetisch bedingte Prädispositionen wie z. B. Polymorphismen im Interleukin-1-Gen identifiziert wurden. Darüber hinaus scheinen muskuläre Erkrankungen wie z. B. das M.-piriformis-Syndrom oder auch myofasziale Schmerzsyndrome eine wichtige Rolle zu spielen. In Bezug auf die medikamentöse Schmerztherapie sollte das Medikament die Schmerzen wirksam unterdrücken, auch in der Langzeitanwendung nebenwirkungsarm bleiben, keine Gewöhnung hervorrufen und Chronifizierungsprozessen entgegenwirken. Der vorliegende Artikel fasst dabei die aus unterschiedlichen Leitlinien empfohlene Vorgehensweise zur medikamentösen Therapie zusammen und wertet kritisch neuere Daten zu einzelnen Substanzen. Auf die im Rahmen eines schmerztherapeutischen Gesamtkonzepts notwendigen nichtmedikamentösen Therapieformen wird in diesem Artikel nicht eingegangen.

Abstract

Chronic low back pain is one of the most frequent diseases in medicine with a high economic burden. The aetiology is heterogenous and multicausal, but recently genetic factors leading to a predisposition such as polymorphism in the interleukin-1 gene have been identified. Muscular diseases like piriformis muscle syndrome or myofascial pain syndrome appear to play an additional role in the pathogenesis. Medical pain treatment should use medications that are potent to reduce low back pain, should exhibit minor side effects and no potential for drug abuse and should prevent chronification. The present article summarises different and recent guidelines for the medical treatment of low back pain and evaluates recent studies investigating different substances. The review also includes a concise summary of non-medication treatment of low back pain but does not go into detail.

Schlüsselwörter

Rückenschmerz - Sensibilisierung - Schmerztherapie

Keywords

low back pain - sensitization - pain treatment
 

  • Literatur

  • 1 Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999; 354: 581-585
    CrossrefPubMedGoogle Scholar
  • 2 Balagué F, Mannion AF, Pellisé F et al. Non-specific low back pain. Lancet 2012; 379: 482-491
    CrossrefPubMedGoogle Scholar
  • 3 Wenig CM, Schmidt CO, Kohlmann T et al. Costs of back pain in Germany. Eur J Pain 2009; 13: 280-286
    CrossrefPubMedGoogle Scholar
  • 4 Borenstein D. Chronic low back pain. Musculosceletal Med 1996; 22: 439-456
    PubMedGoogle Scholar
  • 5 Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001; 344: 363-370
    CrossrefPubMedGoogle Scholar
  • 6 Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM). Kreuzschmerzen. (DEGAM-Leitlinie; 3). Düsseldorf: DEGAM; 2003. http://www.degam.de/leitlinien/3_kreuzschmerzen.html
    Google Scholar
  • 7 Chenot JF, Becker A, Niebling W et al. Aktualisierung der DEGAM-Leitlinie Kreuzschmerzen. Z Allg Med 2007; 83: 487-494
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ). Empfehlungen zur Therapie von Kreuzschmerzen. 3.. Auflage. 2007. http://www.akdae.de/Arzneimitteltherapie/TE/Archiv/Kreuzschmerzen.pdf
    Google Scholar
  • 9 Burton AK, Eriksen HR, Leclerc A et al. European guidelines for prevention in low back pain. European Commission Research Directorate General; 2004
    Google Scholar
  • 10 van Tulder M, Becker A, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. European Commission Research Directorate General; 2005. http://www.backpaineurope.org/web/files/WG1_Guidelines.pdf
    Google Scholar
  • 11 Hildebrandt J, Ursin H, Mannion AF et al. European guidelines for the management of chronic non-specific low back pain. 2005. http://www.backpaineurope.org/web/files/WG2_Guidelines.pdf
    Google Scholar
  • 12 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Kreuzschmerz – Langfassung. Version 1.X. 2010. http://www.versorgungsleitlinien.de/themen/kreuzschmerz
    Google Scholar
  • 13 Werber A, Schiltenwolf M. Chronischer Rückenschmerz. Nervenarzt 2012; 83: 243-257
    CrossrefPubMedGoogle Scholar
  • 14 de Schepper EI, Damen J, van Meurs JB et al. The association between lumbar disc degeneration and low back pain: the influence of age, gender, and individual radiographic. Spine (Phila Pa 1976) 2010; 35: 531-536
    CrossrefPubMedGoogle Scholar
  • 15 Cheung KM, Karppinen J, Chan D et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976) 2009; 34: 934-940
    CrossrefPubMedGoogle Scholar
  • 16 Endean A, Palmer KT, Coggon D. Potential of magnetic resonance imaging findings to refine case definition for mechanical low back pain in epidemiological studies: a systematic review. Spine (Phila Pa 1976) 2011; 36: 160-169
    CrossrefPubMedGoogle Scholar
  • 17 Hopayian K, Song F, Riera R et al. The clinical features of the piriformis syndrome: a systematic review. Eur Spine J 2010; 19: 2095-2109
    CrossrefPubMedGoogle Scholar
  • 18 Ramsook RR, Malanga GA. Myofascial low back pain. Curr Pain Headache Rep 2012; 16: 423-432
    CrossrefPubMedGoogle Scholar
  • 19 Shiri R, Karppinen J, Leino-Arjas P et al. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol 2010; 171: 135-154
    CrossrefPubMedGoogle Scholar
  • 20 Shiri R, Karppinen J, Leino-Arjas P et al. The association between smoking and low back pain: a meta-analysis. Am J Med 2010; 123: 87 e7-35
    CrossrefPubMedGoogle Scholar
  • 21 Kalichman L, Hunter DJ. The genetics of intervertebral disc degeneration. Associated genes. Joint Bone Spine 2008; 75: 388-396
    CrossrefPubMedGoogle Scholar
  • 22 Kalichman L, Hunter DJ. The genetics of intervertebral disc degeneration. Familial predisposition and heritability estimation. Joint Bone Spine 2008; 75: 383-387
    CrossrefPubMedGoogle Scholar
  • 23 Battie MC, Videman T, Levalahti E et al. Heritability of low back pain and the role of disc degeneration. Pain 2007; 131: 272-280
    CrossrefPubMedGoogle Scholar
  • 24 Roffey DM, Wai EK, Bishop P et al. Causal assessment of occupational sitting and low back pain: results of a systematic review. Spine J 2010; 10: 252-261
    CrossrefPubMedGoogle Scholar
  • 25 Roffey DM, Wai EK, Bishop P et al. Causal assessment of awkward occupational postures and low back pain: results of a systematic review. Spine J 2010; 10: 89-99
    CrossrefPubMedGoogle Scholar
  • 26 Roffey DM, Wai EK, Bishop P et al. Causal assessment of occupational standing or walking and low back pain: results of a systematic review. Spine J 2010; 10: 262-272
    CrossrefPubMedGoogle Scholar
  • 27 Roffey DM, Wai EK, Bishop P et al. Causal assessment of workplace manual handling or assisting patients and low back pain: results of a systematic review. Spine J 2010; 10: 639-651
    CrossrefPubMedGoogle Scholar
  • 28 Roffey DM, Wai EK, Bishop P et al. Causal assessment of occupational pushing or pulling and low back pain: results of a systematic review. Spine J 2010; 10: 544-553
    CrossrefPubMedGoogle Scholar
  • 29 Reme SE, Tangen T, Moe T et al. Prevalence of psychiatric disorders in sick listed chronic low back pain patients. Eur J Pain 2011; 15: 1075-1080
    CrossrefPubMedGoogle Scholar
  • 30 Seok H, Son BK, Ha YR et al. Clinical influence of emotional depression on chronic low back pain. J Korean Acad Rehab Med 2003; 27: 568-574
    PubMedGoogle Scholar
  • 31 Gerhardt A, Hartmann M, Schuller-Roma B et al. The prevalence and type of Axis-I and Axis-II mental disorders in subjects with non-specific chronic back pain: results from a population-based study. Pain Med 2011; 12: 1231-1240
    CrossrefPubMedGoogle Scholar
  • 32 Mense S. Pathophysiologie des Rückenschmerzes und seine Chronifizierung. Schmerz 2001; 15: 413-417
    CrossrefPubMedGoogle Scholar
  • 33 Maihöfner C, Nickel FT, Seifert F. Neuropathische Schmerzsyndrome und Neuroplastizität in der funktionellen Bildgebung. Schmerz 2010; 24: 137-145
    CrossrefPubMedGoogle Scholar
  • 34 Kobayashi Y, Kurata J, Sekiguchi M et al. Augmented cerebral activation by lumbar mechanical stimulus in chronic low back pain patients: an FMRI study. Spine (Phila Pa 1976) 2009; 34: 2431-2436
    CrossrefPubMedGoogle Scholar
  • 35 Laine L, Curtis SP, Cryer B et al. Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients. Aliment Pharmacol Ther 2010; 32: 1240-1248
    CrossrefPubMedGoogle Scholar
  • 36 Chan FK, Hung LC, Suen BY et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 2002; 347: 2104-2110
    CrossrefPubMedGoogle Scholar
  • 37 Chan FK, Lanas A, Scheiman J et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet 2010; 376: 173-179
    CrossrefPubMedGoogle Scholar
  • 38 Höer A, Gothe H, Schiffhorst G et al. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease. Pharmacoepidemiol Drug Saf 2007; 16: 854-858
    CrossrefPubMedGoogle Scholar
  • 39 Wallace JL, Syer S, Denou E et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 2011; 141: 1314-1322
    CrossrefPubMedGoogle Scholar
  • 40 Shau WY, Chen HC, Chen ST et al. Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence. BMC Cardiovasc Disord 2012; 12: 4 [Epub ahead of print]
    CrossrefPubMedGoogle Scholar
  • 41 Chang CH, Shau WY, Kuo CW et al. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study. Stroke 2010; 41: 1884-1890
    CrossrefPubMedGoogle Scholar
  • 42 Fosbol EL, Folke F, Jacobsen S et al. Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circ Cardiovasc Qual Outcome 2010; 3: 395-405
    PubMedGoogle Scholar
  • 43 Aljadhey H, Tu W, Hansen RA et al. Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovasc Disord 2012; 12: 93 [Epub ahead of print]
    CrossrefPubMedGoogle Scholar
  • 44 MacDonald TM, Richard D, Lheritier K et al. The effects of lumiracoxib 100 mg once daily vs. ibuprofen 600 mg three times daily on the blood pressure profiles of hypertensive osteoarthritis patients taking different classes of antihypertensive agents. Int J Clin Pract 2010; 64: 746-755
    CrossrefPubMedGoogle Scholar
  • 45 Klawe C, Maschke M. Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound. Expert Opin Pharmacother 2009; 10: 1495-1500
    CrossrefPubMedGoogle Scholar
  • 46 Li C, Ni J, Wang Z et al. Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial. Curr Med Res Opin 2008; 24: 3523-3530
    CrossrefPubMedGoogle Scholar
  • 47 Überall MA, Müller-Schwefe GH, Terhaag B. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study. Curr Med Res Opin 2012; 28: 1617-1634
    CrossrefPubMedGoogle Scholar
  • 48 Deshpande A, Furlan A, Mailis-Gagnon A et al. Opioids for chronic low-back pain. Cochrane Database Syst Rev 2007; (03) CD004959
    PubMedGoogle Scholar
  • 49 Reinecke H, Sorgatz H. S3-Leitlinie LONTS. Schmerz 2009; 23: 440-447
    CrossrefPubMedGoogle Scholar
  • 50 Urquhart DM, Hoving JL, Assendelft WW et al. Antidepressants for non-specific low back pain. Cochrane Database Syst Rev 2008; (01) CD001703
    PubMedGoogle Scholar
  • 51 Holt S, Schmiedl S, Thürmann PA. PRISCUS-Liste potenziell inadäquater Medikation für ältere Menschen. Dtsch Ärztebl 2010; 107: 543-551
    PubMedGoogle Scholar
  • 52 Skljarevski V, Ossanna M, Liu-Seifert H et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 2009; 16: 1041-1048
    CrossrefPubMedGoogle Scholar
  • 53 Mazza M, Mazza O, Pazzaglia C et al. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin Pharmacother 2010; 11: 1049-1052
    CrossrefPubMedGoogle Scholar
  • 54 Skljarevski V, Zhang S, Desaiah D et al. Duloxetine Versus Placebo in Patients With Chronic Low Back Pain: A 12-Week, Fixed-Dose, Randomized, Double-Blind Trial. J Pain 2010; 11: 1282-1290
    PubMedGoogle Scholar
  • 55 Romanò CL, Romanò D, Bonora C et al. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthop Traumatol 2009; 10: 185-191
    CrossrefPubMedGoogle Scholar
  • 56 Kaki AM, El-Yaski AZ, Youseif E. Identifying neuropathic pain among patients with chronic low back pain: use of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale. Reg Anesth Pain Med 2005; 30: 422-428
    PubMedGoogle Scholar
  • 57 Freynhagen R, Baron R, Gockel U et al. Pain detect: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911-1920
    CrossrefPubMedGoogle Scholar